Apyx Medical (APYX) Corporation announces it has received 510(k) clearance from the U.S. Food and Drug Administration for the AYON Body Contouring System. The Company is actively preparing for a commercial launch of AYON with key surgeons in critical geographies starting in the second half of 2025.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APYX: